Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Shares Outstanding (Weighted Average) (2016 - 2022)

Historic Shares Outstanding (Weighted Average) for Nutex Health (NUTX) over the last 14 years, with Q2 2022 value amounting to $646.4 million.

  • Nutex Health's Shares Outstanding (Weighted Average) rose 903.83% to $646.4 million in Q2 2022 from the same period last year, while for Jun 2022 it was $646.4 million, marking a year-over-year increase of 903.83%. This contributed to the annual value of $37.3 million for FY2021, which is 65522.12% up from last year.
  • Per Nutex Health's latest filing, its Shares Outstanding (Weighted Average) stood at $646.4 million for Q2 2022, which was up 903.83% from $37.3 million recorded in Q4 2021.
  • Over the past 5 years, Nutex Health's Shares Outstanding (Weighted Average) peaked at $3.7 billion during Q2 2019, and registered a low of $1.7 million during Q4 2018.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $323.3 million, with a median of $18.6 million in 2021.
  • As far as peak fluctuations go, Nutex Health's Shares Outstanding (Weighted Average) plummeted by 9987.54% in 2020, and later surged by 1264365.68% in 2021.
  • Nutex Health's Shares Outstanding (Weighted Average) (Quarter) stood at $1.7 million in 2018, then soared by 113.22% to $3.6 million in 2019, then surged by 36.15% to $4.9 million in 2020, then surged by 655.22% to $37.3 million in 2021, then soared by 1631.73% to $646.4 million in 2022.
  • Its Shares Outstanding (Weighted Average) stands at $646.4 million for Q2 2022, versus $37.3 million for Q4 2021 and $42.4 million for Q3 2021.